Protein Kinase Inhibitor Market Demand and Competitive Analysis Report by 2025
Global protein kinase inhibitor market is anticipated to grow at a higher CAGR in the forecast period.
Global protein kinase inhibitor market is anticipated to grow at a higher CAGR in the forecast period.
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
<strong>Protein</strong> <strong>Kinase</strong> <strong>Inhibitor</strong> <strong>Market</strong> <strong>Dem<strong>and</strong></strong> <strong>and</strong><br />
<strong>Competitive</strong> <strong>Analysis</strong> <strong>Report</strong> <strong>by</strong> <strong>2025</strong><br />
“Clinically, protein kinases help in underst<strong>and</strong>ing inter <strong>and</strong> intra-cellular molecular<br />
interactions, <strong>and</strong> also explains the role of multiple cellular biochemical networks <strong>and</strong> clarify<br />
unknown details of different cell processes such as division <strong>and</strong> metabolism”<br />
Global protein kinase inhibitor market is anticipated to grow at a higher CAGR in the forecast period. The global<br />
market encompasses extensive R&D <strong>and</strong> favorable funding from private sector that propels the market growth.<br />
Generally, a protein kinase is a kinase enzyme that alters other proteins <strong>by</strong> chemically addition of phosphate groups<br />
to them. <strong>Protein</strong> kinases are indispensable for various cell processes. These enzymes catalyze phosphorylation of<br />
various other cellular substrates. Phosphorylation regulates cellular functions in return. However, protein kinases<br />
can be deregulated under pathological conditions resulting into variations in phosphorylation <strong>and</strong> uncontrolled cell<br />
division, apoptosis inhibition <strong>and</strong> other abnormalities.<br />
Clinically, protein kinases help in underst<strong>and</strong>ing inter <strong>and</strong> intra-cellular molecular interactions, <strong>and</strong> also explains the<br />
role of multiple cellular biochemical networks <strong>and</strong> clarify unknown details of different cell processes such as<br />
division <strong>and</strong> metabolism. Characteristically, protein kinase inhibitors are chemically assorted <strong>and</strong> possess lowmolecular<br />
weight. Along with protein kinases with ATP substrate, there exists a group of ATP non-competitive<br />
inhibitors which describe a group of peptide inhibitors of protein kinases.<br />
Browse Full Research <strong>Report</strong> @<br />
https://www.millioninsights.com/industry-reports/protein-kinase-inhibitor-market
On a commercial scale, protein kinase inhibitors help in diagnosing cancer patients <strong>and</strong> also the rise in dem<strong>and</strong> for<br />
custom treatments has been a prime feature in the growth of protein kinase inhibitor market. Overall, with the<br />
product innovation <strong>and</strong> novel therapies the protein kinase market is expected to rise at a higher CAGR in the<br />
international market. <strong>Protein</strong> kinase inhibitor industry is driven <strong>by</strong> factor such as rising R&D activities against<br />
cancer in developed countries. Additionally, technological innovations <strong>and</strong> data-driven customizations to fulfill<br />
consumer dem<strong>and</strong> for efficiency <strong>and</strong> accurate outcome also propel the market growth in the forecast period.<br />
Moreover, protein kinases as anti-cancer drugs account for a significant share in the global market.<br />
<strong>Protein</strong> <strong>Kinase</strong> inhibitor industry geographically spans North America, Latin America, Asia-Pacific, Europe, Middle-<br />
East <strong>and</strong> Africa. North America dominates the global market in terms of value. Also, factors such as rising R&D<br />
activities in this region propel the market growth in the forecast period. Europe is anticipated to rise at a<br />
tremendous CAGR in the forecast period owing to extensive research on cancer <strong>and</strong> cancerous cells.<br />
APAC regions are anticipated to rise at a higher CAGR in the forecast period owing to rising prevalence of cancer<br />
<strong>and</strong> need for novel therapies. Middle-East <strong>and</strong> African protein kinase inhibitor industry is expected to rise at a<br />
moderate CAGR owing to low medical infrastructure <strong>and</strong> less R&D activities.<br />
Request Sample Copy of This <strong>Report</strong> @<br />
https://www.millioninsights.com/industry-reports/protein-kinase-inhibitor-market/request-sample<br />
The key players in the protein kinase inhibitor industry include Pfizer, Alnylam Pharmaceuticals, Allergan, Amgen,<br />
Biocon, Angstorm Pharmaceuticals, Bionomics, Acceleron Pharma, CASI Pharmaceuticals, Celegene Corporation,<br />
Enzon Pharmaceuticals, Five Prime Therapeutics, Fujifilm Kyowa Kirin Biologics, Hetero Drugs, Genentech, ImClone<br />
Systems, Genexine, Intas Pharmaceuticals, Kyowa Hakko Kirin, Levolta Pharmaceuticals, Marsala Biotech,<br />
Neumedicines, Novartis, Onyx Pharmaceuticals, <strong>and</strong> Oncobiologics.<br />
<strong>Market</strong> Segment:<br />
Geographically, this report is segmented into several key Regions, with production, consumption, revenue<br />
(million USD), market share <strong>and</strong> growth rate of <strong>Protein</strong> <strong>Kinase</strong> <strong>Inhibitor</strong>s in these regions, from 2013 to <strong>2025</strong><br />
(forecast), covering<br />
• North America<br />
• Europe<br />
• China<br />
• Japan
• Southeast Asia<br />
• India<br />
Global <strong>Protein</strong> <strong>Kinase</strong> <strong>Inhibitor</strong>s market competition <strong>by</strong> top manufacturers, with production, price, revenue<br />
(value) <strong>and</strong> market share for each manufacturer; the top players including<br />
• Bayer<br />
• Astra Zeneca<br />
• Roche<br />
• Teva<br />
• Apotex<br />
• Novartis<br />
• Glaxosmithkline<br />
• Pfizer<br />
See More <strong>Report</strong>s of This Category <strong>by</strong> Million Insights @<br />
https://www.millioninsights.com/industry/pharmaceuticals<br />
On the basis of product, this report displays the production, revenue, price, market share <strong>and</strong> growth rate of<br />
each type, primarily split into<br />
• Rx<br />
• OTC<br />
On the basis of the end users/applications, this report focuses on the status <strong>and</strong> outlook for major<br />
applications/end users, consumption (sales), market share <strong>and</strong> growth rate for each application, including<br />
• Hospital<br />
• Clinic<br />
Browse Full Research <strong>Report</strong> @
https://www.millioninsights.com/industry-reports/protein-kinase-inhibitor-market<br />
Get in touch<br />
At Million Insights, we work with the aim to reach the highest levels of customer satisfaction.<br />
Our representatives strive to underst<strong>and</strong> diverse client requirements <strong>and</strong> cater to the same with<br />
the most innovative <strong>and</strong> functional solutions.<br />
Contact Person:<br />
Ryan Manuel<br />
Research Support Specialist, USA<br />
Email: ryan@millioninsights.com<br />
Global Headquarters<br />
Million Insights<br />
Felton Office Plaza 6265 Highway 9<br />
Felton, California 95018, United States<br />
Phone: 1-408-610-2300<br />
Email: sales@millioninsights.com<br />
Asia Pacific<br />
Million Insights<br />
Office No. 302, 3rd Floor, Manikch<strong>and</strong><br />
Galleria, Model Colony, Shivaji Nagar,<br />
Pune, MH, 411016 India<br />
Phone: 91-20-65300184<br />
Email: sales@millioninsights.com<br />
Visit Our Blog: www.millioninsights.blogspot.com
Change language